Reduce genomic testing costs
A subscription model that drives savings, eliminates waste, and delivers value from day one.
Fee-for-service genomics is broken economics.
Every test is a separate transaction. Costs are unpredictable. Data is fragmented across vendors. And there's no mechanism to capture long-term value from the genomic insights you're already paying for. The result: overspending on testing with under-investment in outcomes.
Subscription genomics. Predictable costs. Compounding value.
Helix replaces fee-for-service chaos with a subscription model that consolidates testing, reduces per-test costs, and creates a reusable genomic data asset. Pay once for the sequence, then query it for life—pharmacogenomics, hereditary cancer, cardiac risk, and more.
Key capabilities
Subscription-based pricing
Predictable annual costs replace per-test billing. Budget with confidence and eliminate cost variability across departments.
Test once, query forever
A single exome sequence supports dozens of clinical use cases over a patient's lifetime—no repeat testing, no duplicate costs.
Consolidated vendor management
One platform replaces multiple testing vendors, reducing administrative overhead and simplifying contracting.
Measurable ROI dashboard
Track cost savings, utilization, and clinical impact in real time with Helix's built-in analytics.
See the savings in black and white.
We'll model the cost impact for your health system based on your current testing volume and programs.
Get a cost analysis